Clinical Trials Browser

INDUSTRY × Non-Small Cell Lung Cancer With HER2- Mutations × Clear all

NCT06430437 2026-01-21

A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations

Phase 3 Recruiting

Non-Small Cell Lung Cancer With HER2- Mutations